Table 8:
Net Budget Impact, 2013/2014 | |
---|---|
Prevalence of diagnosed diabetes in Ontario increased by 50% | − $7,053,722 |
HbA1c testing increased by 25% | − $5,878,102 |
HbA1c testing decreased by 25% | − $3,526,861 |
Percentage of patients with suboptimal glycemic control increased by 25% | − $8,315,175 |
Percentage of patients with suboptimal glycemic control increased by 50% | − $11,927,868 |
Impact of increasing POC HbA1c testing by 25% | − $1,175,620 |
Impact of increasing POC HbA1c testing by 50% | − $2,351,241 |
Impact of increasing POC HbA1c testing by 75% | − $3,526,861 |
Physicians’ visits excluded | $11,656,363 |
Abbreviations: HbA1c, hemoglobin A1c; POC HbA1c, point-of-care hemoglobin A1c.